Among the 13 CAR-T therapeutics that have received regulatory approval are Gilead’s Yescarta and Immuneel Therapeutics’ ...

A study of 200 patients with chronic lymphocytic leukemia (CLL) showed a lower rate of severe and serious adverse events among those treated with zanubrutinib compared with ibrutinib.

A new study suggests that small doses of a widely used antibiotic and anti-inflammatory drug could effectively treat a rare ...

Researchers have revealed a new finding that could improve cancer care immunotherapy treatments, particularly for CLL and ...

在血液疾病的世界里，慢性淋巴细胞白血病（Chronic Lymphocytic Leukemia，CLL）是一种常见的恶性肿瘤。近年来，随着医学技术的进步，CLL 患者的治疗取得了一定进展，但当 CLL 发生 Richter 转化（Richter Transformation，RT）时，情况就变得棘手起来。RT 是 CLL 进展过程中出现的一种侵袭性淋巴瘤，预后极差。尽管基因测序技术让我们对 ...

Under the terms of the deal, Sanofi will pay $600 million upfront to buy an affiliate of the California-based biotech, called ...